Literature DB >> 20494327

Management of postpolio syndrome.

Henrik Gonzalez1, Tomas Olsson, Kristian Borg.   

Abstract

Postpolio syndrome is characterised by the exacerbation of existing or new health problems, most often muscle weakness and fatigability, general fatigue, and pain, after a period of stability subsequent to acute polio infection. Diagnosis is based on the presence of a lower motor neuron disorder that is supported by neurophysiological findings, with exclusion of other disorders as causes of the new symptoms. The muscle-related effects of postpolio syndrome are possibly associated with an ongoing process of denervation and reinnervation, reaching a point at which denervation is no longer compensated for by reinnervation. The cause of this denervation is unknown, but an inflammatory process is possible. Rehabilitation in patients with postpolio syndrome should take a multiprofessional and multidisciplinary approach, with an emphasis on physiotherapy, including enhanced or individually modified physical activity, and muscle training. Patients with postpolio syndrome should be advised to avoid both inactivity and overuse of weak muscles. Evaluation of the need for orthoses and assistive devices is often required. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20494327     DOI: 10.1016/S1474-4422(10)70095-8

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  26 in total

1.  Comorbidity profile of poliomyelitis survivors in a Chinese population: a population-based study.

Authors:  Jiunn-Horng Kang; Herng-Ching Lin
Journal:  J Neurol       Date:  2011-01-30       Impact factor: 4.849

2.  Progressive ascending myelopathy: atypical forms of multiple sclerosis or what else?

Authors:  Viviana Nociti; Anna Paola Batocchi; Marco Luigetti; Amelia Conte; Vita Santa Lorusso; Silvia Roiati; Tommaso Tartaglione; Alessandra Del Grande; Mario Sabatelli
Journal:  J Neurol       Date:  2011-04-22       Impact factor: 4.849

Review 3.  Positive muscle phenomena--diagnosis, pathogenesis and associated disorders.

Authors:  Hans G Kortman; Jan H Veldink; Gea Drost
Journal:  Nat Rev Neurol       Date:  2012-01-24       Impact factor: 42.937

4.  IVIG treatment in post-polio patients: evaluation of responders.

Authors:  Gunilla Ostlund; Lisbet Broman; Lars Werhagen; Kristian Borg
Journal:  J Neurol       Date:  2012-05-17       Impact factor: 4.849

5.  Triceps Brachii in Incomplete Tetraplegia: EMG and Dynamometer Evaluation of Residual Motor Resources and Capacity for Strengthening.

Authors:  M Elise Johanson; Zoia C Lateva; Jeffrey Jaramillo; B Jenny Kiratli; Kevin C McGill
Journal:  Top Spinal Cord Inj Rehabil       Date:  2013

Review 6.  Review of secondary health conditions in postpolio syndrome: prevalence and effects of aging.

Authors:  Thomas E McNalley; Kathryn M Yorkston; Mark P Jensen; Anjali R Truitt; Katherine G Schomer; Carolyn Baylor; Ivan R Molton
Journal:  Am J Phys Med Rehabil       Date:  2015-02       Impact factor: 2.159

7.  Functional and environmental factors affecting work status in individuals with longstanding poliomyelitis.

Authors:  Gabi Zeilig; Harold Weingarden; Yeheskel Shemesh; Amir Herman; Michael Heim; Manual Zeweker; Israel Dudkiewicz
Journal:  J Spinal Cord Med       Date:  2012-01       Impact factor: 1.985

8.  Survey of young patients with polio and a foreign background at a Swedish post-polio outpatient clinic.

Authors:  Lars Werhagen; Kristian Borg
Journal:  Neurol Sci       Date:  2016-06-14       Impact factor: 3.307

9.  Complications and outcomes of complex spine reconstructions in poliomyelitis-associated spinal deformities: a single-institution experience.

Authors:  Jakub Godzik; Lawrence G Lenke; Terrence Holekamp; Brenda Sides; Michael P Kelly
Journal:  Spine (Phila Pa 1976)       Date:  2014-07-01       Impact factor: 3.468

10.  Intravenous immunoglobulin treatment of the post-polio syndrome: sustained effects on quality of life variables and cytokine expression after one year follow up.

Authors:  Henrik Gonzalez; Mohsen Khademi; Kristian Borg; Tomas Olsson
Journal:  J Neuroinflammation       Date:  2012-07-09       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.